The Emerging Role of Angiogenic Factor Dysregulation in the Pathogenesis of Polycystic Ovarian Syndrome

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Seminars in Reproductive Medicine

• Publication date

  2015-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0035-1552582PMID 26036901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model.

  2015cited by this paper
• Platelet‐derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients

  2014cited by this paper
• Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation

  2014cited by this paper
• The Role of TGF-β in Polycystic Ovary Syndrome

  2014cited by this paper
• Comparison of bevacizumab and cabergoline in the treatment of ovarian hyperstimulation syndrome in a rat model

  2013cited by this paper
• Primate follicular development and oocyte maturation in vitro.

  2013cited by this paper
• Targeting angiogenesis in the pathological ovary.

  2013cited by this paper
• Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS).

  2013cited by this paper
• Angiopoietin-1 and angiopoietin-2 are altered in polycystic ovarian syndrome (PCOS) during controlled ovarian stimulation

  2013cited by this paper
• Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.

  2013cited by this paper
• Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.

  2012cited by this paper
• Fibroblast growth factor 2 is a key determinant of vascular sprouting during bovine luteal angiogenesis.

  2012cited by this paper
• Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys

  2011cited by this paper
• Effect of laparoscopic ovarian drilling on vascular endothelial growth factor and ovarian stromal blood flow using 3‐dimensional power Doppler

  2011cited by this paper
• Linkage of regulators of TGF‐β activity in the fetal ovary to polycystic ovary syndrome

  2011cited by this paper
• Potential role of follicle‐stimulating hormone (FSH) and transforming growth factor (TGFβ1) in the regulation of ovarian angiogenesis

  2011cited by this paper
• Laparoscopic Ovarian Drilling for Clomiphene-Resistant Polycystic Ovary Syndrome

  2011cited by this paper
• Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

  2010cited by this paper
• Family-based analysis of candidate genes for polycystic ovary syndrome.

  2010cited by this paper
• Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence

  2010cited by this paper
• Estrogens and androgens affect human luteal cell function.

  2010cited by this paper
• Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.

  2010cited by this paper
• A Riddle Wrapped in a Mystery inside an Enigma

  2010cited by this paper
• Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation.

  2010cited by this paper
• A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome.

  2010cited by this paper
• Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review.

  2010cited by this paper
• Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF

  2009cited by this paper
• Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.

  2009cited by this paper
• Superficial ovarian cortex vascularization is inversely related to the follicle reserve in normal cycling ovaries and is increased in polycystic ovary syndrome.

  2009cited by this paper
• Polycystic ovary syndrome--"A riddle wrapped in a mystery inside an enigma".

  2009cited by this paper
• SRB Reproduction, Fertility and Development Award Lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium.

  2009cited by this paper
• Follicle dynamics and anovulation in polycystic ovary syndrome.

  2008cited by this paper
• Soluble receptor-mediated selective inhibition of VEGFR and PDGFRβ signaling during physiologic and tumor angiogenesis

  2008cited by this paper
• The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients.

  2008cited by this paper
• Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.

  2008cited by this paper
• Effect of local neutralization of basic fibroblast growth factor or vascular endothelial growth factor by a specific antibody on the development of the corpus luteum in the cow

  2008cited by this paper
• Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women.

  2007cited by this paper
• The role of metformin in polycystic ovary syndrome: a systematic review.

  2007cited by this paper
• Fibroblast Growth Factor 2 Is More Dynamic than Vascular Endothelial Growth Factor A During the Follicle-Luteal Transition in the Cow1

  2007cited by this paper
• Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.

  2007cited by this paper
• Expression of Vascular Permeability Factor! Vascular Endothelial Growth Factor by Human Granulosa and Theca Lutein Cells Role in Corpus Luteum Development

  2007cited by this paper
• Platelet-Derived Growth Factors and Receptors in the Rat Corpus Luteum: Localization and Identification of an Effect on Luteogenesis1

  2007cited by this paper
• Transforming Growth Factor-&bgr;s and Vascular Disorders

  2006cited by this paper
• Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome

  2006cited by this paper
• Changes in fibroblast growth factor 2 and its receptors in bovine follicles before and after GnRH application and after ovulation.

  2006cited by this paper
• Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.

  2006cited by this paper
• Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation

  2006cited by this paper
• Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome.

  2006cited by this paper
• Vascular morphogenesis in the primate ovary

  2005cited by this paper
• Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome.

  2005cited by this paper
• Angiogenesis in the human corpus luteum: changes in expression of angiopoietins in the corpus luteum throughout the menstrual cycle and in early pregnancy.

  2005cited by this paper
• Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

  2005cited by this paper
• Angiopoietin-2 Causes Inflammation in Vivo by Promoting Vascular Leakage

  2005cited by this paper
• Local Delivery of Angiopoietin-2 into the Preovulatory Follicle Terminates the Menstrual Cycle in Rhesus Monkeys1

  2005cited by this paper
• Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.

  2005cited by this paper
• Power Doppler ultrasound assessment of ovarian perifollicular blood flow in women with polycystic ovaries and normal ovaries during in vitro fertilization treatment.

  2005cited by this paper
• Platelet-derived growth factor--an introduction.

  2004cited by this paper
• Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography.

  2004cited by this paper
• Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?

  2004cited by this paper
• PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis.

  2004cited by this paper
• Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle.

  2004cited by this paper
• Angiogenesis in health and disease

  2003cited by this paper
• Angiogenesis in the corpus luteum

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Fibroblast Growth Factor (FGF), Intracellular Adhesion Molecule (sICAM‐1) Level in Serum and Follicular Fluid of Infertile Women with Polycystic Ovarian Syndrome, Endometriosis and Tubal Damage, and their Effect on ICSI Outcome

  2003cited by this paper
• Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development.

  2003cited by this paper
• Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries.

  2003cited by this paper
• Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.

  2003cited by this paper
• Formation and early development of follicles in the polycystic ovary.

  2003cited by this paper
• Localization of vascular endothelial growth factor in the zona pellucida of developing ovarian follicles in the rat: a possible role in destiny of follicles

  2003cited by this paper
• Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome.

  2003cited by this paper
• Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women.

  2003cited by this paper
• Altered Expression of Angiopoietins During Blood-Brain Barrier Breakdown and Angiogenesis

  2003cited by this paper
• Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis.

  2002cited by this paper
• Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase.

  2002cited by this paper
• New members of the platelet-derived growth factor family of mitogens.

  2002cited by this paper
• Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2.

  2002cited by this paper
• Characterization of Normal and Polycystic Ovaries Using Three-Dimensional Power Doppler Ultrasonography

  2002cited by this paper
• Angiogenesis in the Corpus Luteum of Early Pregnancy in the Marmoset and the Effects of Vascular Endothelial Growth Factor Immunoneutralization on Establishment of Pregnancy

  2002cited by this paper
• Signal transduction by the TGF-beta superfamily.

  2002cited by this paper
• Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata.

  2002cited by this paper
• Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries.

  2002cited by this paper
• Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols.

  2001cited by this paper
• Human endometrial angiogenesis.

  2001cited by this paper
• Angiogenesis in the primate ovary.

  2001cited by this paper
• Polycystic ovary syndrome: relationship between insulin sensitivity ,sex hormone levels and ovarian stromal blood flow

  2001cited by this paper
• Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway.

  2001cited by this paper
• Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis

  2001cited by this paper
• Regulation and action of angiogenic factors in the primate ovary.

  2001cited by this paper
• Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)).

  2001cited by this paper
• Vascular Endothelial Growth Factor Production in Growing Pig Antral Follicles1

  2000cited by this paper
• Transforming Growth Factor &bgr; in Hypertensives With Cardiorenal Damage

  2000cited by this paper
• Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle.

  2000cited by this paper
• Regulation of Transforming Growth Factor-β-Receptor Type I and Type II Messenger Ribonucleic Acid Expression in the Hamster Ovary by Gonadotropinsand Steroid Hormones1

  2000cited by this paper
• Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome.

  2000cited by this paper
• Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles.

  2000cited by this paper
• Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age.

  2000cited by this paper
• Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders.

  2000cited by this paper
• Angiogenesis and its control in the female reproductive system.

  2000cited by this paper
• Angiogenesis in ovarian follicular and luteal development.

  2000cited by this paper

• Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes

  2025cites this paper
• Elevated level of platelet factor 4 in follicular fluid is associated with polycystic ovary syndrome.

  2025cites this paper
• Probiotics mitigates ovarian angiogenic disturbance in letrozole-induced PCOS

  2025cites this paper
• Exploring some pro-inflammatory cytokines and adipokines as novel biomarkers in polycystic ovary syndrome

  2025cites this paper
• The role of estrogen metabolites in human ovarian function.

  2024cites this paper
• Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review

  2024cites this paper
• Oxidative Stress and the Nrf2/PPARγ Axis in the Endometrium: Insights into Female Fertility

  2024cites this paper
• Ameliorative potential of rosmarinic acid in a rat model of polycystic ovary syndrome: Targeting MCP‐1 and VEGF: A histological, immunohistochemical, and biochemical study

  2024cites this paper
• The IL-12 family of heterodimeric cytokines in polycystic ovarian syndrome: biological role in induction, regulation, and treatment

  2024cites this paper
• Modulating Morphological and Redox/Glycative Alterations in the PCOS Uterus: Effects of Carnitines in PCOS Mice

  2023cites this paper
• Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis

  2023cites this paper
• Optimal Anti-Müllerian Hormone in Oocyte Donors: a national database analysis.

  2023cites this paper
• Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome

  2023cites this paper
• Value of Assessing AMH in the Management of Polycystic Ovarian Syndrome (PCOS)

  2023cites this paper
• Changes in growth factors in polycystic ovarian syndrome

  2023cites this paper
• Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.

  2023cites this paper
• Expression and Clinical Significance of HIF-1α in Follicular Fluid and Granulosa Cells in Infertile PCOS Patients

  2023cites this paper
• Impact of Vitamin D Deficiency on the Pathogenesis of Polycystic Ovary Syndrome

  2022cites this paper
• High-intensity interval training in polycystic ovarian syndrome: An evidence-based review

  2022cites this paper
• Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry.

  2022cites this paper
• A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome

  2022cites this paper
• High-Fat Diet and Female Fertility across Lifespan: A Comparative Lesson from Mammal Models

  2022cites this paper
• Ovarian Hyperstimulation Syndrome after GnRH Agonist Triggering and Freeze-All Protocol? Never Not, Hardly Ever: A Systematic Review of Case Reports

  2022cites this paper
• Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation: implications for fertility.

  2022cites this paper
• Impact of increasing antimüllerian hormone level on in vitro fertilization fresh transfer and live birth rate

  2022cites this paper
• Follicular fluid PlGF and IVF/ICSI outcomes among PCOS and normo-ovulatory women using different controlled hyperstimulation protocols: A prospective case-control study

  2022cites this paper
• Polycystic ovaries: problematics, etiology, pathogenesis (literary review)

  2022cites this paper
• Transcriptomic Analysis Reveals Endometrial Dynamics in Normoweight and Overweight/Obese Polycystic Ovary Syndrome Women

  2022cites this paper
• Antioxidant effects of vitamin E and risk of cardiovascular disease in women with obesity - A narrative review.

  2022cites this paper
• Transcriptional and DNA Methylation Signatures of Subcutaneous Adipose Tissue and Adipose-Derived Stem Cells in PCOS Women

  2022cites this paper
• An integrated in silico analysis highlighted angiogenesis regulating miRNA-mRNA network in PCOS pathophysiology

  2022cites this paper
• Altered Molecular Pathways and Biomarkers of Endometrial Receptivity in Infertile Women with Polycystic Ovary Syndrome

  2022cites this paper
• Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome

  2021cites this paper
• Role of Vascular Endothelial Growth Factor (VEGF) in Human Embryo Implantation: Clinical Implications

  2021cites this paper
• Variations in the Profiles of Vascular-Related Factors Among Different Sub-Types of Polycystic Ovarian Syndrome in Northern China

  2021cites this paper
• The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?

  2021cites this paper
• A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D

  2021cites this paper
• Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS

  2021cites this paper
• The association between Angiopoietin-2 and the risk of recurrent implantation failure

  2021cites this paper
• Severe Ovarian Hyperstimulation Syndrome in a Woman With Breast Cancer Under Letrozole Triggered With GnRH Agonist: A Case Report and Review of the Literature

  2021cites this paper
• Potential of thrombospondin-1 in treatment of polycystic ovary syndrome rat model: a preliminary study

  2021cites this paper
• Resveratrol and Markers of Polycystic Ovary Syndrome: a Systematic Review of Animal and Clinical Studies

  2021cites this paper
• Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper.

  2021cites this paper
• The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis

  2021cites this paper
• Characterization of microRNA, mRNA, and Protein Expression in Large and Cystic Bovine Follicles

  2021cites this paper
• Impact of Polycystic Ovary Syndrome, Metabolic Syndrome, Obesity, and Follicular Growth Arrest in Women Health

  2021cites this paper
• Serum Levels of PDGF, EGF, and sFlt-1 in Patients with Polycystic Ovary Syndrome and Their Predictive Effects on Pregnancy Outcomes

  2021cites this paper
• Association between VEGF gene polymorphisms (11 sites) and polycystic ovary syndrome risk

  2020cites this paper
• Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome.

  2020cites this paper
• Vitamin D Supplementation Ameliorates Metabolic Dysfunction in Patients with PCOS: A SystematicReview of RCTs and Insight into the Underlying Mechanism

  2020cites this paper
• Effect of Vitamin E on Serum Levels of Vascular Endothelial Growth Factor and Angiopoietin-1 in Women with Polycystic Ovary Syndrome: A Pilot Randomized, Placebo-Controlled Trial

  2020influential citation
• Endometrial function in women with polycystic ovary syndrome: a comprehensive review.

  2020cites this paper
• VEGF gene rs35569394 polymorphism in patients with Polycystic Ovary Syndrome.

  2020cites this paper
• Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis

  2020cites this paper
• High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology

  2020cites this paper
• Downregulation of Lnc-OC1 attenuates the pathogenesis of polycystic ovary syndrome.

  2020cites this paper
• Haplotype analysis of VEGF gene polymorphisms in polycystic ovary syndrome

  2019cites this paper
• Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome

  2019cites this paper
• Mechanisms of Insulin Resistance Formation in Polycystic Ovarian Disease and Therapeutic Effects from Myo Inositol

  2019cites this paper
• Flutamide ameliorates uterine decidualization and angiogenesis in the mouse hyperandrogenemia model during mid-pregnancy

  2019cites this paper
• Hormonal regulation of vascular endothelial growth factor A (VEGFA) gene expression in granulosa and theca cells of cattle1.

  2019cites this paper
• Silencing of LncRNA steroid receptor RNA activator attenuates polycystic ovary syndrome in mice.

  2019cites this paper
• Adiponectin and Chemerin: Contrary Adipokines in Regulating Reproduction and Metabolic Disorders

  2018influential citation
• The in fl uences of vitamin D and omega-3 co-supplementation on clinical , metabolic and genetic parameters in women with polycystic ovary syndrome

  2018cites this paper
• MicroRNA Regulation of Ovarian Angiogenesis and Folliculogenesis in Bovine Cystic Ovarian Disease

  2018cites this paper
• Ovulation: Parallels With Inflammatory Processes.

  2018cites this paper
• Endogenous Ovarian Angiogenesis in Polycystic Ovary Syndrome-Like Rats Induced by Low-Frequency Electro-Acupuncture: The CLARITY Three-Dimensional Approach

  2018cites this paper
• The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.

  2018cites this paper
• Platelets are involved in in vitro swine granulosa cell luteinization and angiogenesis.

  2018cites this paper
• Inositol(s) from Bench to Bedside in Endocrinology and Gynecology

  2017cites this paper
• The role of Notch signalling in ovarian angiogenesis

  2017cites this paper
• Oocyte Competence in Women with Polycystic Ovary Syndrome.

  2017cites this paper
• THE ROLE OF SYMPATHICOTONIC REACTIVITY OF ORGANISM AND GROWTH FACTORS IN PATHOGENESIS OF SYNDROME OF POLYCYSTIC OVARY

  2017cites this paper
• Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial

  2017cites this paper
• Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome

  2017influential citation
• Local administration of platelet-derived growth factor B (PDGFB) improves follicular development and ovarian angiogenesis in a rat model of Polycystic Ovary Syndrome.

  2016cites this paper
• Sonographic evaluation of polycystic ovaries.

  2016cites this paper
• Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with PCOS

  2016cites this paper
• Inositol Treatment and ART Outcomes in Women with PCOS

  2016cites this paper
• Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.

  2015cites this paper